Reasoning gaps hold back AI agents in scientific discovery
MIT Technology Review argues AI agents need reasoning, not just more data, to accelerate science.
Trending Now
OpenAI launches GPT-Rosalind for life sciences research
The frontier reasoning model is designed to accelerate drug discovery and biological research across chemistry, protein engineering, and genomics.
Teladoc puts 100 percent of fees at risk with new AI-powered platform
The rebuilt Teladoc One platform links payment to patient outcomes, using AI…
Johns Hopkins finds frontier AI agents fail most complex health tasks
A benchmark test found leading AI agents completed only 28% of healthcare…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
AI-focused venture firm Dimension restocks with $800M third fund
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing…
Gates and Bezos back LifeMine’s $188M fungal drug revival
LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and…
Pathos AI bets $125M on ADC its agent platform flagged
Pathos AI is paying $125M upfront for an Alphamab Oncology ADC that its Foundry agent…
First AI-found brain target advances in Recursion-Roche pact
The first neuroscience target found through Recursion's $12B AI pact with Roche and Genentech is…
AI pilots prove value then stall in most health systems
A Carta Healthcare survey finds 71% of organizations with measurable AI wins are not scaling…
Pharma AI Alliance Expands: Owkin and AstraZeneca Deploy New Drug Discovery Models
Owkin and AstraZeneca are expanding their AI collaboration to develop new drug discovery models using…
Taiwan University-Hospital Alliance Accelerates AI Integration into Clinical Care
A new long-term partnership between National Sun Yat-sen University and Kaohsiung Veterans General Hospital aims…
Drug metabolism AI contest shows data matters more than model size
Inductive Bio won the openADMET competition, but a 28-way statistical tie suggests data quality may…